BAM Logo

SARS-CoV-2 Point of Care

[SARS-CoV-2 Point of Care]

EPTIS factsheet 935461 | Last revision 2022-05-13 | URL: https://www.eptis.bam.de/pts935461 https://www.eptis.bam.de/pts935461

PT provider
PT provider UK NEQAS for Microbiology UK NEQAS for Microbiology
Based in United Kingdom
Language(s) English
Product groups Human test material
Testing fields Microbiology
Technical details
Test item Tested property Testing method
Simulated nasopharyngeal swab/ aspirate in viral transport medium or molecular grade water; simulated sputum in viral transport medium or molecular grade water To determine the presence / absence of SARS-CoV-2 antigen/ nucleic acid by point of care devices such as lateral flow, LAMP and antigen test Point of care
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants
Accredited or otherwise reviewed by a 3rd party

Accredited by United Kingdom Accreditation Service on the basis of accreditation pending

Operation is commissioned / requested by
Fees and frequency
Participation fee
Regularly operated Yes (6 per annum)
Year of first operation 2021
Contact details of the PT provider
Provider Contact person
UK NEQAS for Microbiology
PO Box 63003
NW9 1GH London
United Kingdom

Phone: +44 (0) 20 8905 9890
Fax: +44 (0) 20 8205 1488
Web: http://www.ukneqasmicro.org.uk http://www.ukneqasmicro.org.uk
Ms. Priya Patel
Phone: +44 (0) 20 8327 7573
Email: organiser@ukneqasmicro.org.uk organiser@ukneqasmicro.org.uk
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom, Mr Savvas Xystouris. Mr Savvas Xystouris.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21